An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
from NDTV News - Topstories https://ift.tt/3rZxcwb
from NDTV News - Topstories https://ift.tt/3rZxcwb
Comments
Post a Comment